Skip to main content
. 2010 Jul-Sep;17(3):264–267. doi: 10.4103/0974-9233.65500

Table 1.

Preoperative characteristics and treatment of eight subjects with retinopathy of prematurity that underwent laser therapy and intravitreal bevacizumab injection

Case # Sex Date of birth Zone Stage of ROP Birth weight (g) Gestational age (weeks) Postmenstrual age at the time of laser (weeks) Postmenstrual age at the time of injections (weeks) Eye
1 M 08.07.08 2 4a+,3+ 860 27 33 33 OU
2 F 05.03.08 2 3+,4a 820 29 36 36 OU
3 F 29.08.07 3 3,3 1200 29 37 37 OU
4 F 13.04.07 1 3+,3+ 1000 32 38 38 OD
5 M 22.11.07 2 3,3 1200 29 36 38 OU
6 F 20.06.07 2 3,3 800 29 38 38 OU
7 M 01.06.07 2 3,4b 1220 29 37,41 37,41 OU
8 M 20.04.07 2 3+,3+ 1020 29 37 37 OU

OU - bilateral; OD - right eye; OS - left eye; M - male; F - female